Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)
Clinical trial NCT06145802 · WITHDRAWN
Trial details
- NCT number
- NCT06145802
- Sponsor
- Grit Biotechnology
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-09
- Primary completion
- 2025-12-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.